Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ian Hiles is active.

Publication


Featured researches published by Ian Hiles.


Cell | 1992

Phosphatidylinositol 3-kinase : structure and expression of the 110 kd catalytic subunit

Ian Hiles; Masayuki Otsu; Stefano Volinia; Michael J. Fry; Ivan Gout; Ritu Dhand; George Panayotou; Fernanda Ruiz-Larrea; Andrew Thompson; Nicholas F. Totty; J. Justin Hsuan; Sara A. Courtneidge; Peter J. Parker; Michael D. Waterfield

Purified bovine brain phosphatidylinositol 3-kinase (Pl3-kinase) is composed of 85 kd and 110 kd subunits. The 85 kd subunit (p85 alpha) lacks Pl3-kinase activity and acts as an adaptor, coupling the 110 kd subunit (p110) to activated protein tyrosine kinases. Here the characterization of the p110 subunit is presented. cDNA cloning reveals p110 to be a 1068 aa protein related to Vps34p, a S. cerevisiae protein involved in the sorting of proteins to the vacuole. p110 expressed in insect cells possesses Pl3-kinase activity and associates with p85 alpha into an active p85 alpha-p110 complex that binds the activated colony-stimulating factor 1 receptor. p110 expressed in COS-1 cells is catalytically active only when complexed with p85 alpha.


Cell | 1991

Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase.

Masayuki Otsu; Ian Hiles; Ivan Gout; Michael J. Fry; Fernanda Ruiz-Larrea; George Panayotou; Andrew Thompson; Ritu Dhand; J. Justin Hsuan; Nicholas F. Totty; Anthony D. Smith; Sarah J. Morgan; Sara A. Courtneidge; Peter J. Parker; Michael D. Waterfield

Affinity-purified bovine brain phosphatidylinositol 3-kinase (PI3-kinase) contains two major proteins of 85 and 110 kd. Amino acid sequence analysis and cDNA cloning reveals two related 85 kd proteins (p85 alpha and p85 beta), which both contain one SH3 and two SH2 regions (src homology regions). When expressed, these 85 kd proteins bind to and are substrates for tyrosine-phosphorylated receptor kinases and the polyoma virus middle-T antigen/pp60c-src complex, but lack PI3-kinase activity. However, an antiserum raised against p85 beta immunoprecipitates PI3-kinase activity. The active PI3-kinase complex containing p85 alpha or p85 beta and the 110 kd protein binds to PDGF but not EGF receptors. p85 alpha and p85 beta may mediate specific PI3-kinase interactions with a subset of tyrosine kinases.


Cell | 1993

The GTPase dynamin binds to and is activated by a subset of SH3 domains

Ivan Gout; Ritu Dhand; Ian Hiles; Michael J. Fry; George Panayotou; Pamela Das; Oanh Truong; Nicholas F. Totty; J. Justin Hsuan; Grant W. Booker; Iain D. Campbell; Michael D. Waterfield

Src homology 3 (SH3) domains have been implicated in mediating protein-protein interactions in receptor signaling processes; however, the precise role of this domain remains unclear. In this report, affinity purification techniques were used to identify the GTPase dynamin as an SH3 domain-binding protein. Selective binding to a subset of 15 different recombinant SH3 domains occurs through proline-rich sequence motifs similar to those that mediate the interaction of the SH3 domains of Grb2 and Abl proteins to the guanine nucleotide exchange protein, Sos, and to the 3BP1 protein, respectively. Dynamin GTPase activity is stimulated by several of the bound SH3 domains, suggesting that the function of the SH3 module is not restricted to protein-protein interactions but may also include the interactive regulation of GTP-binding proteins.


The EMBO Journal | 1994

PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity.

Ritu Dhand; Ian Hiles; George Panayotou; Roche S; Michael J. Fry; Ivan Gout; Nicholas F. Totty; Oanh Truong; Vicendo P; Kazuyoshi Yonezawa

Phosphatidylinositol 3‐kinase (PI 3‐kinase) has a regulatory 85 kDa adaptor subunit whose SH2 domains bind phosphotyrosine in specific recognition motifs, and a catalytic 110 kDa subunit. Mutagenesis of the p110 subunit, within a sequence motif common to both protein and lipid kinases, demonstrates a novel intrinsic protein kinase activity which phosphorylates the p85 subunit on serine at a stoichiometry of approximately 1 mol of phosphate per mol of p85. This protein‐serine kinase activity is detectable only upon high affinity binding of the p110 subunit with its unique substrate, the p85 subunit. Tryptic phosphopeptide mapping revealed that the same major peptide was phosphorylated in p85 alpha both in vivo in cultured cells and in the purified recombinant enzyme. N‐terminal sequence and mass analyses were used to identify Ser608 as the major phosphorylation site on p85 alpha. Phosphorylation of the p85 subunit at this serine causes an 80% decrease in PI 3‐kinase activity, which can subsequently be reversed upon treatment with protein phosphatase 2A. These results have implications for the role of inter‐subunit serine phosphorylation in the regulation of the PI 3‐kinase in vivo.


The EMBO Journal | 1994

PI 3-kinase: structural and functional analysis of intersubunit interactions.

Ritu Dhand; K. Hara; Ian Hiles; Ben Bax; Ivan Gout; George Panayotou; Michael J. Fry; Kazuyoshi Yonezawa; M. Kasuga; M D Waterfield

Phosphatidylinositol (PI) 3‐kinase has an 85 kDa subunit (p85 alpha) which mediates its association with activated protein tyrosine kinase receptors through SH2 domains, and an 110 kDa subunit (p110) which has intrinsic catalytic activity. Here p85 alpha and a related protein p85 beta are shown to form stable complexes with recombinant p110 in vivo and in vitro. Using a panel of glutathione S‐transferase (GST) fusion proteins of the inter‐SH2 region of p85, 104 amino acids were found to bind directly the p110 protein, while deletion mutants within this region further defined the binding site to a sequence of 35 amino acids. Transient expression of the mutant p85 alpha protein in mouse L cells showed it was unable to bind PI 3‐kinase activity in vivo. Mapping of the complementary site of interaction on the p110 protein defined 88 amino acids in the N‐terminal region of p110 which mediate the binding of this subunit to either the p85 alpha or the p85 beta proteins. The inter‐SH2 region of p85 is predicted to be an independently folded module of a coiled‐coil of two long anti‐parallel alpha‐helices. The predicted structure of p85 suggests a basis for the intersubunit interaction and the relevance of this interaction with respect to the regulation of the PI 3‐kinase complex is discussed.


Molecular and Cellular Biology | 1993

Interactions between SH2 domains and tyrosine-phosphorylated platelet-derived growth factor beta-receptor sequences: analysis of kinetic parameters by a novel biosensor-based approach.

George Panayotou; G Gish; Peter End; Oanh Truong; Ivan Gout; Ritu Dhand; Michael J. Fry; Ian Hiles; T Pawson; M D Waterfield

The interaction between SH2 domains and phosphotyrosine-containing sequences was examined by real-time measurements of kinetic parameters. The SH2 domains of the p85 subunit of the phosphatidylinositol 3-kinase as well as of other signaling molecules were expressed in bacteria as glutathione S-transferase fusion proteins. Phosphotyrosine-containing peptides, corresponding to two autophosphorylation sites on the human platelet-derived growth factor beta-receptor that are responsible for phosphatidylinositol 3-kinase binding, were synthesized and used as capturing molecules, immobilized on a biosensor surface. The association and dissociation rate constants for binding to both sites were determined for intact p85 and the recombinant SH2 domains. High association rates were found to be coupled to very fast dissociation rates for all interactions studied. A binding specificity was observed for the two SH2 domains of p85, with the N-terminal SH2 binding with high affinity to the Tyr-751 site but not to the Tyr-740 site, and the C-terminal SH2 interacting strongly with both sites. This approach should be generally applicable to the study of the specificity inherent in the assembly of signaling complexes by activated protein-tyrosine kinase receptors.


Nature | 1993

Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system

Mark Marchionni; Andrew Goodearl; Maio Su Chen; Olivia Bermingham-McDonogh; Cassandra Kirk; Marvin Hendricks; Frank Danehy; Don Misumi; Judith Sudhalter; Kazumi Kobayashi; Diana Wroblewski; Catherine Lynch; Mark Baldassare; Ian Hiles; John B. Davis; J. Justin Hsuan; Nicholas F. Totty; Masayuki Otsu; Robert N. McBurney; Michael D. Waterfield; Paul Stroobant; David I. Gwynne


Science | 1994

Phospholipase D: a downstream effector of ARF in granulocytes

Shamshad Cockcroft; Geraint M.H. Thomas; Amanda Fensome; B. Geny; Emer Cunningham; Ivan Gout; Ian Hiles; N F Totty; Oanh Truong; J. Justin Hsuan


Genomics | 1994

Molecular cloning, cDNA sequence, and chromosomal localization of the human phosphatidylinositol 3-kinase p110{alpha} (PIK3CA) gene

Stefano Volinia; Ian Hiles; Elizabeth Ormondroyd; Dean Nizetic; Rachele Antonacci; Mariano Rocchi; Michael O. Waterfield


Archive | 1993

Glial mitogenic factors, their preparation and use

Andrew Goodearl; Paul Stroobant; Luisa Minghetti; Michael Chantemerlc Waterfield; Mark Marchioni; Maio Su Chen; Ian Hiles

Collaboration


Dive into the Ian Hiles's collaboration.

Top Co-Authors

Avatar

Paul Stroobant

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Luisa Minghetti

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Mark Marchioni

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Ivan Gout

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Michael J. Fry

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Ritu Dhand

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

George Panayotou

National Institute for Medical Research

View shared research outputs
Top Co-Authors

Avatar

Mario Su Chen

Ludwig Institute for Cancer Research

View shared research outputs
Researchain Logo
Decentralizing Knowledge